Radiopharm Theranostics (RADX) Retained Earnings (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Retained Earnings for 2 consecutive years, with -$145.7 million as the latest value for Q2 2025.

• Quarterly Retained Earnings fell 484.21% to -$145.7 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$145.7 million through Jun 2025, down 484.21% year-over-year, with the annual reading at -$145.7 million for FY2025, 484.21% down from the prior year.
• Retained Earnings for Q2 2025 was -$145.7 million at Radiopharm Theranostics, down from $37.9 million in the prior quarter.
• The five-year high for Retained Earnings was $37.9 million in Q2 2024, with the low at -$145.7 million in Q2 2025.

Peer Comparison